168 related articles for article (PubMed ID: 37331671)
1. Functionalized chitosan for cancer nano drug delivery.
Zaiki Y; Iskandar A; Wong TW
Biotechnol Adv; 2023 Oct; 67():108200. PubMed ID: 37331671
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Gold Nanoparticle-Incorporated Chitosan Nanogels as a Theranostic Nanoplatform for CT Imaging and Tumour Chemotherapy.
Liu Z; Zhou D; Yan X; Xiao L; Wang P; Wei J; Liao L
Int J Nanomedicine; 2022; 17():4757-4772. PubMed ID: 36238536
[TBL] [Abstract][Full Text] [Related]
4. Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan-Based Nanocarriers.
Caprifico AE; Polycarpou E; Foot PJS; Calabrese G
Macromol Biosci; 2021 Jan; 21(1):e2000312. PubMed ID: 33016007
[TBL] [Abstract][Full Text] [Related]
5. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
[TBL] [Abstract][Full Text] [Related]
6. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
Choi KO; Choe J; Suh S; Ko S
Molecules; 2016 May; 21(5):. PubMed ID: 27213324
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics.
Ashrafizadeh M; Ahmadi Z; Mohamadi N; Zarrabi A; Abasi S; Dehghannoudeh G; Tamaddondoust RN; Khanbabaei H; Mohammadinejad R; Thakur VK
Int J Biol Macromol; 2020 Feb; 145():282-300. PubMed ID: 31870872
[TBL] [Abstract][Full Text] [Related]
8. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity.
Ryu JH; Yoon HY; Sun IC; Kwon IC; Kim K
Adv Mater; 2020 Dec; 32(51):e2002197. PubMed ID: 33051905
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
11. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
[TBL] [Abstract][Full Text] [Related]
12. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
13. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
14. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
Tian B; Hua S; Liu J
Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
[TBL] [Abstract][Full Text] [Related]
15. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
Ezhilarasan D; Lakshmi T; Mallineni SK
Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
[TBL] [Abstract][Full Text] [Related]
16. Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges.
Sachdeva B; Sachdeva P; Negi A; Ghosh S; Han S; Dewanjee S; Jha SK; Bhaskar R; Sinha JK; Paiva-Santos AC; Jha NK; Kesari KK
Mar Drugs; 2023 Mar; 21(4):. PubMed ID: 37103352
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea-loaded Fe
Chaghervand MM; Torbati MB; Shaabanzadeh M; Ahmadi A; Tafvizi F
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):51-63. PubMed ID: 34661718
[TBL] [Abstract][Full Text] [Related]
18. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment.
Yee Kuen C; Masarudin MJ
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056788
[TBL] [Abstract][Full Text] [Related]
20. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
